Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 17.30
-0.30 (-1.70%)
Jan 21, 2026, 2:10 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 124.24 million as of January 21, 2026. Its market cap has decreased by -48.31% in one year.
Market Cap
124.24M
Enterprise Value
87.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.30
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 124.24M, an increase of 147.44%. That is a compound annual growth rate of 10.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 122.12M | -12.63% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 183.58M |
| IRLAB Therapeutics AB | 161.21M |
| Sprint Bioscience AB | 157.75M |
| Biovica International AB | 126.11M |
| Active Biotech AB | 111.77M |
| Biosergen AB | 93.93M |
| Pila Pharma AB | 89.64M |
| Spago Nanomedical AB | 85.67M |